Neumonía eosinofílica crónica secundaria a levetiracetam

Identifiers
Identifiers
Date issued
2022Journal title
Revista Española de Casos Clínicos en Medicina Interna (RECCMI)
Type of content
Artículo
Abstract
Eosinophilic pulmonary diseases constitute a very heterogeneous group of diseases that share clinical manifestations, radiological and/or laboratory findings. Therefore, it is necessary to know the diagnostic criteria for each disease. Chronic idiopathic eosinophilic pneumonia is the most common eosinophilic pneumonia in non-tropical areas where parasitic infections is low. If a clear cause is identified, the most frequent is secondary to drugs and/or toxins. We present the case of a 21-year-old man diagnosed with chronic eosinophilic pneumonia secondary to treatment with levetiracetam, a generally safe and widely accepted drug in routine clinical practice. A search for the etiology of eosinophilic pulmonary diseases is essential, because identifying a possible cause would allow the withdrawal of the causative agent and to start corticosteroid therapy, so we could prevent the associated morbidity and mortality.
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
